Epistatic interactions of CDKN2B-TCF7L2 for risk of type 2 diabetes and of CDKN2B-JAZF1 for triglyceride/high-density lipoprotein ratio longitudinal change: evidence from the Framingham Heart Study (Q33519368)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Epistatic interactions of CDKN2B-TCF7L2 for risk of type 2 diabetes and of CDKN2B-JAZF1 for triglyceride/high-density lipoprotein ratio longitudinal change: evidence from the Framingham Heart Study |
scientific article |
Statements
1 reference
Epistatic interactions of CDKN2B-TCF7L2 for risk of type 2 diabetes and of CDKN2B-JAZF1 for triglyceride/high-density lipoprotein ratio longitudinal change: evidence from the Framingham Heart Study (English)
1 reference
Ingrid Borecki
1 reference
Michael Province
1 reference
Mary Feitosa
1 reference
Ping An
1 reference
Shamika Ketkar
1 reference
Avril Adelman
1 reference
Shiow Lin
1 reference
15 December 2009
1 reference
1 reference
3 Suppl 7
1 reference
S71
1 reference
1 December 2009
1 reference
Identifiers
1 reference
1 reference
1 reference